ANI Pharmaceuticals Inc (ANIP)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	454,334	287,962	202,731	198,984	206,547
Property, plant and equipment	US$ in thousands	44,593	43,246	52,671	41,269	40,551
Fixed asset turnover		10.19	6.66	3.85	4.82	5.09

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $454,334K ÷ $44,593K
= 10.19

ANI Pharmaceuticals Inc's fixed asset turnover has shown a positive trend over the past five years, reflecting the company's efficiency in generating revenue from its fixed assets. The ratio has steadily increased from 5.09 in 2019 to 10.92 in 2023, indicating that the company is utilizing its fixed assets more effectively to generate sales. This improvement suggests that ANI Pharmaceuticals has been able to increase its revenue relative to the investment in fixed assets, which can be a positive sign of operational efficiency and management effectiveness. Overall, the increasing trend in fixed asset turnover demonstrates the company's ability to optimize the use of its fixed assets to drive sales growth.